Litcius/Paper detail

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau, Gordon Sussman, Michihiro Hide, Sarbjit S. Saini, Clive Grattan, Daria Fomina, Dimitrios Rigopoulos, F. Bérard, Giorgio Walter Canonica, Heike Röckmann, Carla Irani, Jacek C. Szepietowski, Jeffrey Leflein, Jonathan A. Bernstein, Jonny Peter, Kanokvalai Kulthanan, Kiran Godse, Ledit Ardusso, Olga Ukhanova, Petra Staubach, Rodney Sinclair, S. Gogate, Simon Francis Thomsen, Tonny Tanus, Young‐Min Ye, Alis Burciu, Avantika Barve, Darshna Modi, Emil Scosyrev, Eva Hua, Kerstin Letzelter, Vineeth Varanasi, Manmath Patekar, Thomas Severin, Agondi Rosana, A. Ahmed, Almerigogna Fabio, Alonso Miguel Angel Tejedor, Ammoury Alfred, Anne Goh Eng Kim, A Robert, Ardusso Ledit, Arenberger Petr, AS Nandini, Asefi Mohammad, A.C Aditya Natalia, Badhwar Anil, Baldrich Esther Serra, Bangert Christine, Barbaud Annick, Bata-Csorgo Zsuzsanna, Bauer Andrea, Berard Frederic, Bergler-Czop Beata, Berman Gary D, Bernstein Jonathan, Bharija Subhash Chandra, Bhat Ramesh M, Boccon-Gibod Isabelle, Botev Ivan, Brockow Knut, B. Philipp, Busse Paula, Campos Regis, Canonica Giorgio Walter, Carla Irani, Carmen Julia Maria Del, Carpio Jaime Del, C Mamatha, Yoon‐Seok Chang, Cheema Amarjit, Chen Yi Hsing, Yuko Chinuki, Cho Soyun, Choi Jeong-Hee, Chu Chia-Yu, Confino Ronit, Corren Jonathan, Criado Roberta, Cruz Claudia De La, Cypcar David M, Daftary Pramila, Danilycheva Inna, Dawes Kenneth, De Vera Michelle Joy, Deangelo James, Del Giacco Stefano, Diana Deleanu, D. Martínez-St John, D. Richard, Denguezli Mohamed, Dickel Heinrich, Doanh Le Huu, Dogan Sinan, Doutre Marie Sylvie, Dupond Anne Sophie, Edin Anton, Edward Kent

2023The Lancet64 citationsDOI

Topics & Concepts

MedicinePhase (matter)PediatricsInternal medicinePhysical therapyOrganic chemistryChemistryUrticaria and Related ConditionsCoagulation, Bradykinin, Polyphosphates, and AngioedemaDrug-Induced Adverse Reactions
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | Litcius